In human medicine, reduced PON-1 activity has been documented in several disorders associated with oxidative stress, including cardiovascular diseases, chronic kidney disease (CKD), diabetes mellitus, chronic liver failure, and pancreatitis [8,9,10]. Here, PON1 is linked to chronic kidney disease.